Latest close: below its 200-day averageSep 8, 2026what changed →
The financials
Cencora by the numbers
Cencora (COR) reported revenue of $84.8B in Q3 2026 (quarter ended Jun 30, 2026), up 5.1% from the same quarter a year earlier. That came with a gross margin of 4.3% and net income of $764M (0.9% of revenue). For the full year FY2025, revenue was $321.3B (+9.3% year on year) and net income $1.55B. Its largest segment in Q3 2026 was US Healthcare Solutions at $74.9B, 92% of the disclosed total, well ahead of International Healthcare Solutions at 8.1%.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $84.8B | $80.7B | +5.1% |
| Gross profit | $3.61B | $2.91B | +24% |
| Operating income | $1.12B | $868M | +29% |
| Net income | $764M | $687M | +11% |
| Diluted EPS | $3.94 | $3.52 | +12% |
| Operating | Revenue | Share |
|---|---|---|
| US Healthcare Solutions | $74.9B | 92% |
| International Healthcare Solutions | $6.60B | 8.1% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q3 2026Total $81.46B (+8.2%)
International Healthcare Solutions grew +6.0% year on yearUS Healthcare Solutions +4.9% year on year
Segment Latestquarter on quarteryear on year
- US Healthcare Solutions$74.86B$74.86BQoQ +8.9%year on year +4.9%+8.9%+4.9%
- International Healthcare Solutions$6.60B$6.60BQoQ +1.3%year on year +6.0%+1.3%+6.0%